THIS WEBINAR HAS BEEN CANCELED
We apologize for the inconvenience. Stay up to date on upcoming BioPharma Dive webinars and events by subscribing to our newsletter or visiting BioPharmaDive.com

The challenges—and opportunities—for medical device clinical trials have never been more palpable. With global annual sales forecasted to rise over 5 percent a year and reach nearly US$800 billion by 2030, manufacturers are operating in a changed universe marked by AI, ML, and connected technologies. While these developments have contributed to mounting interest and investment in medical devices, regulatory expectations around new devices have grown more complex. 

That scrutiny, paired with other market disruptions such as revenue strains and declining healthcare spend, have pushed sponsors to double down on proving clinical utility not just to investors and the FDA, but additionally to payers, providers and patients.

Join us for this webinar where industry leaders will discuss these trends and explore what can be gleaned from biopharma as the medical device industry evolves. You will learn:

• Best practices that have crossover applications from biopharma to medical devices
• How these practices can support evidentiary needs for regulatory submissions
• Examples of commercial successes enabled by following those practices

SPEAKERS

Seema Sayani PhD - MODERATOR
Lead, R&D practice (North America) for the Industry Solutions Group (ISG)
Cognizant

Nirav Dalal
Divisional Vice president, Global Data Science & Analytics
Abbott

Kavitha Lokesh
VP, Head of Life Sciences R&D Industry Solutions & Products
Cognizant